Brussels presses for progress on lead markets for eHealth[fr][de] 

"The prospective return on investment of eHealth is relatively high when compared to the costs inherent in the health sector," argues a Commission report on accelerating the development of the eHealth market in Europe , published in late December 2007.

The report, drafted by a Commission eHealth task force, comprising representatives of several DGs, sketches out a number of policy recommendations for areas of intervention up to 2010.

The recommendations, directed at industry, member states and other eHealth stakeholders, focus on four main obstacles to the development of the eHealth lead market, namely:

• Reducing market fragmentation and lack of interoperability through pilot actions, benchmarking, standardisation and certification; 
• improving legal certainty and consumer acceptance by possibly adopting a legal initiative for eHealth and telemedicine as well as an initiative to enforce personal data protection legislation, disseminating best practice and guidelines; 
• optimising funding opportunities through strengthened national and community R&D co-operation on eHealth; and; 
• improving procurement by facilitating the expression of public demand through more innovation-friendly procurement activities and networking public procurers.

Just days before the publication of the report, the Commission adopted a new strategy on investing public money in high-risk technological research. The initiative seeks to clarify possible conflicts of this type of investment with EU state aid rules and procurement regulations and envisages flexibility for the member states to co-operate with suppliers across borders in risk-benefit sharing.